The phospholipase C-catalysed breakdown of inositol-containing phospholipids is an important source of diacylglycerol in cells stimulated by several agonists. However, recent experimental evidence suggests that major phospholipids such as phosphatidylcholine may also be substrates of the phosphodiesteratic hydrolysis activated by hormones, growth factors and oncogene products. We show here that stimulation of muscarinic agonists activates the release of phosphocholine, which, along with diacylglycerol, is a metabolic product of phospholipase C-mediated hydrolysis of phosphatidylcholine. Fluoroaluminates mimic this muscarinic effect, strongly suggesting that carbachol-activated release of phosphocholine may be mediated by a guanine-nucleotide-binding protein. Evidence for this was obtained from experiments using permeabilized cells in which non-hydrolysable analogues of GTP activated phosphocholine release synergistically with carbachol.
INTRODUCTION
A number of studies have shown the importance of phospholipid metabolism in the control of cellular activation [1, 2] . Most of the work has been focused on phosphoinositide (PI) turnover [3] , whereby phospholipase C (PLC)-mediated hydrolysis of inositol-containing phospholipids (PtdInsPs) generates at least two second messengers [3] : inositol 1,4,5-trisphosphate and diacylglycerol (DAG). The former participates, in collaboration with its metabolic product (inositol 1,3,4,5- tetrakisphosphate) in the control of cytosolic Ca2l levels [4] . DAG, on the other hand, is an important cofactor for protein kinase C (PKC) [5] , and a possible source of arachidonic acid [6, 7] . Cytosolic Ca2" and PKC appear to be key steps in signal-transduction pathways that regulate important cellular functions, including secretion [8, 9] , cell growth [10] and tumour transformation [11] .
More recently, it has been shown that part of the DAG produced in cells stimulated by different agonists did not arise from the phosphodiesteratic hydrolysis of PtdlnsPs [12] . This would indicate that sources of DAG other than PI turnover may be stimulated by some ligands. Interestingly, PLC-catalysed breakdown ofphosphatidylcholine (PtdCho) and phosphatidylethanolamine has been reported to occur in response to several stimuli ranging from hormones and growth factors [13] [14] [15] to oncogene products [16] . This would indicate that not only PtdlnsPs but also major phospholipids, such as PtdCho and phosphatidylethanolamine, could contribute to the DAG generated during cellular stimulation.
The activation of muscarinic cholinergic receptors results in the triggering of various signal-transduction pathways. These include: inhibition of adenylate cyclase (AC) through a G-protein sensitive to pertussis toxin (Gi) , and activation of a PI-specific PLC [17] . Methanolic cell extracts were fractionated into chloroform and aqueous phases as previously described [19] . The presence and levels of intracellular PCho were evaluated in the aqueous phases by t.l.c. as described above.
Cyclic AMP assay Cells grown in 22 mm-diameter plastic culture dishes (Costar, U.S.A.) were made quiescent by 24 h of serum starvation. After incubation for 10 min in the presence of 3-isobutyl-1-methylxanthine (final concn. 1 mM), cholera toxin (100 ng/ml) was added and the incubation was continued for another 10 min. Afterwards, cells were treated with different agonists for 3 min, and reactions were terminated by adding trichloroacetic acid (10 %, w/v). In some experiments cells were treated with pertussis toxin (400 ng/ml) for 24 h. Cyclic AMP in trichloroacetic acid-soluble extracts was determined with a commercially available radioimmunoassay kit (NEN, Boston, MA, U.S.A.). Measurement of PCho production in permeabilized cells Cells labelled as above were washed twice with Ca2+-and Mg2"-free phosphate-buffered saline (0.5 mMMgCl2/0.3 mM-KCl/137 mM-NaCl/8 mM-Na2HPO4/ 1.5 mM-KH2PO4, pH 7.4) followed by two washes with high-K+ medium (KCI, 140 mM; NaCl, 20 mM; MgCl2, 2 mM; ATP, 2 mM; Pipes, 20 mM; EGTA, 1 mM; pH 6.8) with a free Ca2+ concentration of 0.3 gM, before addition of digitonin (50 ,ug/ml) for a period of 4 min at 37 'C. The digitonin was removed by washing cells twice with high-K+ medium, after which agonists were added for different times.
RESULTS
In order to examine whether cholinergic stimulation was associated with PLC-mediated hydrolysis of PtdCho, the following experiment was performed. Swiss 3T3 fibroblasts were labelled with [14C]choline, as described in the Materials and methods section. Afterwards, label was washed out and cell cultures were equilibrated for 20 min in label-free medium, after which 20 mmacetylcholine (ACho) was added and reactions were stopped at different times. Under these conditions, PCho released both extracellularly and into the intracellular milieu was measured. Results shown in Fig. 2 indicate that the effect of CCho on the release of PCho is a dose-dependent phenomenon. These data also show that the concentration of agonists resulting in 50 % of the maximal effects was 0.5 mm.
In additional experiments we examined the pharmacology of cholinergic-stimulated PCho release. Atropine is a well-known antagonist of muscarinic receptors, and hence is a useful tool to investigate the involvement of this type of receptors in CCho-stimulated release of PCho. Results shown in Fig. 3 indicate that preincubation of cells in the presence of atropine (400 /lM) for 10 min before agonist addition abolished CCho-induced release of PCho. These results suggest that the effects of this stimulant on the phosphodiesteratic degradation of PtdCho takes place by stimulation of muscarinic receptors. In order to assess further the pharmacological specificity of CCho actions on PtdCho metabolism, labelled cell cultures were activated, for different times, either with muscarinic (i.e. muscarine) or nicotine (i.e. 1,1-dimethyl-4-phenylpiperazonium; DMPP) agonists, after which PCho release was measured. Results shown in Fig. 4 clearly indicate that whereas muscarine produced a dramatic release of PCho, little or no alteration was observed in this parameter when cells were challenged with DMPP. Taken together, these results indicate that muscarinic stimulation of Swiss 3T3 fibroblasts is associated with PLC-mediated degradation of PtdCho.
AC inhibition is a well-known effect of muscarinic stimulation [17] . In order to demonstrate the presence of functional muscarinic receptors in the cell system used here, the following experiments were carried out. Cells were either untreated or treated with cholera toxin (which ADP-ribosylates the a-subunit of G. (stimulatory Gprotein), leading to the permanent activation of AC; see ref. [20] ) for 10 min before the addition of CCho (20 mM) or muscarine (2 mM). Cyclic AMP levels in cholera- toxin-treated cells were 0.42 + 0.02 pmol/well, whereas untreated cultures had 0.10+0.01 pmol of cyclic AMP/well. The addition of CCho to cholera-toxintreated cells decreased the production of cyclic AMP to 0.15 + 0.02 pmol/well, whereas addition of this agonist to cholera-toxin-treated cells which had previously been exposed to atropine (400 4uM) for 10 min decreased cyclic AMP only to 0.34+0.03 pmol/well. This indicates that atropine blocks the ability of CCho to inhibit choleratoxin-activated AC; this is in agreement with the notion that CCho is acting through a muscarinic receptor. In this regard, it is noteworthy that muscarine (2 mM) addition to cholera-toxin-treated cells decreased cyclic AMP production to 0. 17 + 0.02 pmol/well. The effect of muscarinic agonists on AC is mediated by Gi [17] . The ADP-ribosylation of the a-subunit of this G-protein, by treatment with pertussis toxin, uncouples the effect of muscarinic receptors on AC [21] . Interestingly, CCho addition to pertussis-toxin-treated cells was unable to inhibit cyclic AMP production induced by cholera toxin (results not shown).
Recent experimental evidence indicates that muscarinic stimulation of PI-specific PLC is mediated by a still uncharacterized G-protein [22] . Therefore it was decided to investigate whether this sort of transducing protein could possibly be involved in muscarinic stimulation of PtdCho-specific PLC. To address this point, we took advantage of the capability of fluoroaluminates to stimulate G-proteins in the absence of agonists, in intact cells. but sustained, at least up to 20 min after the stimulant addition. When cells were treated with CCho (20 mM) in the presence of NaF (5 mM), a transient release of PCho was observed (results not shown), which suggests that the sustained activation of PtdCho-PLC detected in response to AlF4-was not due to a hypothetical inhibition of extracellular degradation of PCho. The activating effect of NaF plus AlCl3 on the release of extracellular PCho was dose-dependent. Fig. 6 shows the absolute requirement for AlCl3 (which by itself was without effect) for NaF to stimulate PLC-mediated degradation of PtdCho. These data clearly indicate that the ability of NaF plus AlCl3 to increase the release of PCho in the cell system used here cannot be ascribed to artifactual effects of NaF owing to its phosphataseinhibitory properties, but are a consequence of the direct activation of a G-protein.
In order to demonstrate that muscarinic stimulation of PtdCho-PLC is actually mediated by a G-protein, the following experimental approach was used. ["4C]Cholinelabelled cells were permeabilized with digitonin as described in the Materials and methods section, after which they were incubated with CCho (20 mM) for 2 min either in the absence or in the presence of GTP [S] [25] , a similar response in terms of PCho release to that described here in Swiss 3T3 fibroblasts. One of the signaltransduction pathways activated in response to this type of cholinergic agonists includes the inhibition of AC through a pertussis-toxin-sensitive G-protein (G1). As a control for the presence of actual functional muscarinic receptors in Swiss 3T3 fibroblasts, we showed that CCho was able to inhibit cholera-toxin-activated AC in Swiss 3T3 fibroblasts. This effect of CCho was abolished by addition of atropine to the cell cultures, and was not detected in pertussis-toxin-treated fibroblasts. All these data clearly demonstrate the presence of functional muscarinic receptors in these cells. Therefore this supports our suggestion that CCho and ACho activation of PtdCho-specific PLC in Swiss 3T3 fibroblasts is actually mediated by the stimulation of muscarinic receptors.
Besides inhibiting AC, muscarinic stimulation has been shown to be associated with a significant increase in the release of metabolic products of PI turnover [26] . In our cellular system we observed little or no change in the retease of inositol phosphates in response to stimulation with CCho (results not shown). A similar lack of activation of PI-specific PLC in response to muscarinic stimulation has been found in the neuroblastoma x glioma cell line NG 108-15 [17] . These cells, however, respond to the muscarinic challenge by efficiently inhibiting AC. Contrarily, the human astrocytoma cell line 1321N does not respond to muscarinic activation by inhibiting AC, but does, however, respond to this challenge by releasing inositol phosphates [17] . These data support the idea of the existence of muscarinic-receptor subtypes that selectively interact with. either signal-transduction pathway. The recent cloning and expression of genes corresponding presumably to different receptor subtypes has confirmed this assumption. Thus, whereas M 1 and M4 receptors efficiently activate PI turnover and-poorly regulate AC, M2 and M3 receptors show completely opposite behaviour [27, 28] . The fact that muscarinic stimulation of Swiss 3T3 fibroblasts. induces the release of PCho and significantly inhibits AC, but does not activate PI-specific PLC, permits one-to suggest that the muscarinic-receptor subtype responsible for activation of PtdCho-specific PLC is not M1 or M4. Most probably it will be M2, M3 or a still unidentified subtype.
On the other hand, according to the results presented here, muscarinic stimulation appears to be coupled to PtdCho-specific PLC through a G-protein. Evidence for this suggestion is based on the fact that fluoroaluminates are potent activators of this phospholipid-degradative activity and that GTP [S] activates PCho release synergistically with CCho in digitonin-permeabilized cells. In this regard, it should be noted that Irving & Exton [29] have recently presented experimental evidence showing the existence of a G-protein that couples purinergic stimulation in rat liver membranes to a PtdCho-specific PLC. Interestingly, both G-proteins, that described by Irving & Exton [29] and that described here, are insensitive to pertussis toxin.
It is also worth noting that the release of PCho to the extracellular medium in muscarinic-stimulated cell occurs without changes in the intracellular levels of this metabolite. Interestingly, Rosoff et al. [14] have shown the sequential activation of extracellular PCho release, followed by an increase in the intracellular levels of this metabolite, in interleukin-l-activated T lymphocytes. Whether changes in both types of PCho may also play different roles in cellular activation is not known. In any case, both types of PCho arise as consequence of PtdCho degradation via PLC [14] . This pathway will produce DAG molecular species different from those originated as a consequence of PI-turnover activation. The stimulation of this novel phospholipid-degradative pathway will occur without changes in intracellular Ca2" levels. The recent isolation of a tDNA clone encoding a protein kinase activatable by DAG but independent of Ca2" [30] permit one to speculate on the possible targets of the DAG produced from the activation of PtdCho-specific PLC. On the other hand, the fact that PCho increases in response to muscarinic stimulation are detected only into the extracellular medium might indicate that the DAG produced as consequence of activation of PtdCho hydrolysis may not have access to intracellular PKC. This could mean that this DAG would be acting through PKC-independent routes. All these possibilities are attractive challenges for further research. 
